These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

828 related items for PubMed ID: 31774373

  • 1. LncRNA MALAT1 regulates trophoblast cells migration and invasion via miR-206/IGF-1 axis.
    Wu HY, Wang XH, Liu K, Zhang JL.
    Cell Cycle; 2020 Jan; 19(1):39-52. PubMed ID: 31774373
    [Abstract] [Full Text] [Related]

  • 2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Jan; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 3. Hsa_circ_0088196 suppresses trophoblast migration and invasion by the miR-525-5p/ABL1 axis and the PI3K/AKT signaling pathway.
    Shi F, Li L.
    J Biochem Mol Toxicol; 2022 Oct; 36(10):e23150. PubMed ID: 35781906
    [Abstract] [Full Text] [Related]

  • 4. lncRNA PROX1-AS1 mediates the migration and invasion of placental trophoblast cells via the miR-211-5p/caspase-9 axis.
    Tang D, Geng L, Ma J.
    Bioengineered; 2021 Dec; 12(1):4100-4110. PubMed ID: 34288800
    [Abstract] [Full Text] [Related]

  • 5. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y, Xiao G, Chen Y, Deng Y.
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [Abstract] [Full Text] [Related]

  • 6. SNHG22 promotes migration and invasion of trophoblasts via miR-128-3p/PCDH11X axis and activates PI3K/Akt signaling pathway.
    Wei X, Yuan Y, Yang Q.
    Clinics (Sao Paulo); 2022 Sep; 77():100055. PubMed ID: 35679761
    [Abstract] [Full Text] [Related]

  • 7. The decreased lncRNA ZEB2-AS1 in pre-eclampsia controls the trophoblastic cell line HTR-8/SVneo's invasive and migratory abilities via the miR-149/PGF axis.
    Gao Y, Guo X, Li Y, Sha W, She R.
    J Cell Biochem; 2019 Oct; 120(10):17677-17686. PubMed ID: 31148230
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of miR-299 suppressed the invasion and migration of HTR-8/SVneo trophoblast cells partly via targeting HDAC2 in pre-eclampsia.
    Gao Y, She R, Wang Q, Li Y, Zhang H.
    Biomed Pharmacother; 2018 Jan; 97():1222-1228. PubMed ID: 29145147
    [Abstract] [Full Text] [Related]

  • 9. Upregulated long noncoding RNA Linc00261 in pre-eclampsia and its effect on trophoblast invasion and migration via regulating miR-558/TIMP4 signaling pathway.
    Cheng D, Jiang S, Chen J, Li J, Ao L, Zhang Y.
    J Cell Biochem; 2019 Aug; 120(8):13243-13253. PubMed ID: 30891826
    [Abstract] [Full Text] [Related]

  • 10. LncRNA TDRG1/miR-214-5p axis affects preeclampsia by modulating trophoblast cells.
    Gong F, Cheng H, Shi Y, Cui L, Jia G.
    Cell Biochem Funct; 2020 Jun; 38(4):352-361. PubMed ID: 31885100
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-3935 promotes human trophoblast cell epithelial-mesenchymal transition through tumor necrosis factor receptor-associated factor 6/regulator of G protein signaling 2 axis.
    Jin M, Xu S, Li J, Yao Y, Tang C.
    Reprod Biol Endocrinol; 2021 Sep 07; 19(1):134. PubMed ID: 34493304
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury through the PI3K/Akt/eNOS pathway by sponging miRNA-133a-3p to target IGF1R expression.
    Liu XM, Zhang Z, Zhong J, Li N, Wang T, Wang L, Zhang Q.
    Eur J Pharmacol; 2022 Feb 05; 916():174719. PubMed ID: 34968461
    [Abstract] [Full Text] [Related]

  • 13. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
    Shi B, Wang Y, Yin F.
    Cancer Biol Ther; 2017 Oct 03; 18(10):792-800. PubMed ID: 28857668
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of long non-coding RNA H19 promotes invasion and autophagy via the PI3K/AKT/mTOR pathways in trophoblast cells.
    Xu J, Xia Y, Zhang H, Guo H, Feng K, Zhang C.
    Biomed Pharmacother; 2018 May 03; 101():691-697. PubMed ID: 29522949
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H, Ding Y, Yang X.
    Biomed Res Int; 2021 May 03; 2021():6619730. PubMed ID: 34250088
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T, Chen H, Wang P, Yang N, Bao J.
    Cancer Biother Radiopharm; 2020 Nov 03; 35(9):661-672. PubMed ID: 32275162
    [Abstract] [Full Text] [Related]

  • 17. LncRNA MALAT1 affects the migration and invasion of trophoblast cells by regulating FOS expression in early-onset preeclampsia.
    Li Q, Wang T, Huang S, Zuo Q, Jiang Z, Yang N, Sun L.
    Pregnancy Hypertens; 2020 Jul 03; 21():50-57. PubMed ID: 32408074
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K/AKT/mTOR pathway accommodation.
    Chen J, Yue C, Xu J, Zhan Y, Zhao H, Li Y, Ye Y.
    Placenta; 2019 Jul 03; 82():17-24. PubMed ID: 31174622
    [Abstract] [Full Text] [Related]

  • 19. The knockdown of MALAT1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating MiR-206 / VEGFA axis.
    Wang S, Ren L, Shen G, Liu M, Luo J.
    Mol Cell Probes; 2020 Jun 03; 51():101540. PubMed ID: 32084582
    [Abstract] [Full Text] [Related]

  • 20. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z, Ma Z, Xu X.
    Oncol Rep; 2019 Feb 03; 41(2):1113-1121. PubMed ID: 30431104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.